Inventor
HING C. WONG
Inventor
US
Overview
Patents· 35 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
C07KPeptides25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C12NMicroorganisms or enzymes14%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture4%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
A21DTreatment of flour or dough for baking, e.g. by addition of materials2%
C12YEnzymes2%
B01DSeparation1%
PatentTitleYear
12,594,323Methods of reducing neuroinflammation202612,497,462Anti-CD26 proteins and uses thereof202512,479,899Multi-chain chimeric polypeptides and uses thereof202512,410,224IL-15-based fusions to IL-7 and IL-21202512,398,189Methods of activating regulatory T cells202512,371,472Multimeric IL-15 soluble fusion molecules and methods of making and using same202512,318,432BCG and IL-15 based molecules202512,268,731Compositions comprising IL-15N72D-based molecules and bacillus calmette-guerin (BCG)202512,268,732IL-15-based molecules with anti-CD20 antibody and methods of use202512,233,116IL-15-based fusions to IL-12 and IL-18202512,187,763Chromatography resin and uses thereof202512,186,372IL-15-based molecules and methods of treating a neoplasia202512,168,680Fusion molecules and IL-15 variants202412,115,191Methods of treating age-related and inflammatory diseases202412,097,244Methods of treating a neoplasia with IL-15-based molecules and CTLA-4 antibody202412,024,545Methods of treating aging-related disorders202411,992,516Compositions comprising IL-15-based molecules and immune checkpoint inhibitor antibodies202411,975,059IL-15-based fusions to IL-12 and IL-18202411,965,007IL-15-based fusions to IL-7 and IL-21202411,925,676Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complex202411,890,323Method of treating cancer with composition comprising IL-15-based molecules and BCG202411,872,272IL-15-based fusions to IL-12 and IL-18202411,845,783Multimeric IL-15 soluble fusion molecules and methods of making and using same202311,738,052Multi-chain chimeric polypeptides and uses thereof202311,679,144IL-15-based molecules and methods of use thereof202311,673,932Fusion molecules and IL-15 variants202311,612,645IL-15-based fusions to IL-12 and IL-18202311,571,470IL-15-based fusions to IL-12 and IL-18202311,498,950Fusion molecules and IL-15 variants202211,471,511IL-15-based molecules and methods of use thereof202211,369,679Multimeric IL-15-based molecules202211,365,231Interleukin 15 (IL-15) variants202211,318,201Multimeric IL-15-based molecules202211,173,191IL-15-based molecules and methods of use thereof202111,161,890IL-15-based fusions to IL-7 and IL-212021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to ALTOR BIOSCIENCE LLC (27)· patent assignee history
2021–2026Based in US· patent location history
2023–2025Patents assigned to HCW BIOLOGICS INC (3)· patent assignee history
2023Patents assigned to HCW BIOLOGIES INC (1)· patent assignee history
2024–2026Patents assigned to IMMUNITYBIO INC (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALTOR BIOSCIENCE LLC | 27 | 2021–2025 |
| IMMUNITYBIO INC | 5 | 2024–2026 |
| HCW BIOLOGICS INC | 3 | 2023–2025 |
| HCW BIOLOGIES INC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 35 | 2021–2026 |